Seer, Inc.
SEER
Rank in Stocks
#19986
Seer, Inc. is a life sciences firm specializing in developing and... Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Share Price
$1.68
Last synced: 2026-11-09
Market Cap
$93.02M
Change (1 day)
3.07%
Change (1 year)
-18.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Seer, Inc. (SEER)
Category
Healthcare
Operating Margin for Seer, Inc. (SEER)
Operating Margin as of November 2026 TTM: -511.39%
According to Seer, Inc.'s latest financial reports, its current operating margin (TTM) is -511.39%. At the end of 2025 the company had an operating margin of -483.85%.
Operating Margin history for Seer, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -511.39% | 5.69% |
| 2025 | -483.85% | -32.59% |
| 2024 | -717.72% | 3.83% |
| 2023 | -691.23% | 3.53% |
| 2022 | -667.64% | -40.46% |
| 2021 | -1,121.30% | -78.14% |
| 2020 | -5,129.42% | -64.76% |
| 2019 | -14,554.31% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.08% |
US
|
|
| -149.01% | -99.71% |
US
|
|
| 25.57% | -100.05% |
AU
|
|
| 31.23% | -100.06% |
BE
|
|
| 29.35% | -100.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Seer, Inc.'s operating margin
What is Seer, Inc.'s operating margin?
Seer, Inc.'s operating margin is -511.39%, as of Nov 2026.
What was Seer, Inc.'s operating margin in 2025?
In 2025, Seer, Inc.'s operating margin was -483.85%, compared with -717.72% in 2024.
How has Seer, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Seer, Inc.'s operating margin was highest in 2025 (-483.85%) and lowest in 2020 (-5,129.42%).
How does Seer, Inc.'s operating margin compare with similar companies?
Seer, Inc.'s operating margin (-511.39%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.